The IP and life sciences team at Stibbe works closely with the firm's public law department to advise on regulatory issues affecting pharma companies and other key players in the healthcare sector. Recent highlights have ranged from representing clients in disputes with the Belgian pricing authorities, to assisting with the development of clinical trials. Ignace Vernimme and Philippe Campolini are the key senior names to note.
Legal 500 Editorial commentary
Work highlights
- Representing a major global producer of generic and biosimilar pharmaceutical products in proceedings before the CJEU against the European Commission in relation to an exemption granted to one of its competitors on the market exclusivity of its product.
- Advising a global developer of medicines on a government tender for the processing of Belgian blood in medicines.
- Advising a global developer of medicines on a new pricing model for advanced therapy medicinal products whereby the payments for the products are spread out over several years.
Practice head
The lawyer(s) leading their teams.
Ignace Vernimme, Philippe Campolini